Anika to participate in 43rd Annual J.P. Morgan Healthcare Conferenc

Anika Therapeutics, Inc. a global leader in joint preservation and early intervention orthopedics, announced that Dr. Cheryl Blanchard, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for January 16, 2025, and will provide insights into the company’s strategic initiatives and advancements in orthopedic solutions. This is one of the most prominent events in the healthcare industry, gathering leaders from the sector to discuss innovation and growth.

Dr. Blanchard’s presentation will focus on Anika’s position as a leader in joint preservation, showcasing the company's innovations in early intervention orthopedics. It will cover recent achievements, product advancements, and the company’s long-term goals in improving joint health and mobility. The session will highlight Anika’s efforts to address the global demand for orthopedic solutions through cutting-edge technologies and a patient-centered approach.

Additionally, Anika’s management team will participate in one-on-one investor meetings throughout the conference, allowing for deeper discussions on the company’s growth prospects and strategic direction. For those unable to attend in person, the presentation will be webcast live and available for on-demand viewing for 30 days following the event. This webcast will be accessible on Anika Therapeutics’ website, reinforcing the company's commitment to transparency and engaging with stakeholders worldwide.